Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036524 | SCV000060179 | benign | not specified | 2015-08-06 | criteria provided, single submitter | clinical testing | p.Gly422Ser in exon 20 of ELN: This variant is not expected to have clinical sig nificance because it has been identified in 42% (27817/66734) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs2071307). |
Prevention |
RCV000036524 | SCV000304569 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000264113 | SCV000469904 | benign | Supravalvar aortic stenosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000319237 | SCV000469905 | benign | Cutis laxa, autosomal dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000036524 | SCV000709166 | benign | not specified | 2017-06-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000264113 | SCV001721335 | benign | Supravalvar aortic stenosis | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000036524 | SCV003929209 | likely benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712006 | SCV005272920 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000036524 | SCV001742226 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000036524 | SCV001807639 | benign | not specified | no assertion criteria provided | clinical testing |